Wegovy is the weight-management version of semaglutide, and for most of its life it was priced like a luxury good: Novo Nordisk still lists it at $1,349.02 per package. What changed is that the company now sells it straight to cash payers at roughly a quarter of that, and the discount does not require being uninsured. Anyone paying out of pocket can use it.
The complication is that “the price of Wegovy” is now four different numbers depending on whether you buy a pen or a tablet, whether you are a new patient, and which door you walk through. This guide lays out every published self-pay price as of August 2026, verified directly on Novo Nordisk’s own NovoCare and Wegovy pages, plus what the drug costs at an ordinary pharmacy counter if you skip the program.
What Does Wegovy Cost Without Insurance?
Here is the full 2026 picture. “Low” is the cheapest published price, “Average” is what a typical self-pay patient pays month to month, and “High” is the ceiling for that route.
| Option | Low | Average | High |
|---|---|---|---|
| Wegovy pen, NovoCare self-pay (0.25 to 2.4 mg) | $199/mo (first 2 fills) | $349/mo | $349/mo |
| Wegovy HD 7.2 mg pen, NovoCare self-pay | $199/mo (first 2 fills) | $399/mo | $399/mo |
| Wegovy tablets, NovoCare self-pay | $149/mo (1.5 mg) | $199/mo (4 mg) | $299/mo (9 and 25 mg) |
| Commercial insurance with Novo savings card | $25/mo | $25/mo | Savings capped at $100/mo |
| Retail pharmacy, no manufacturer program | ~$1,011/mo (SingleCare, tablets) | ~$1,209/mo (SingleCare, 4 pens) | ~$1,820/mo (typical cash, tablets) |
| Novo Nordisk list price | - | $1,349.02 per package | - |
Program prices come from Novo Nordisk’s published NovoCare Pharmacy and Wegovy.com pages as of August 2026. Retail figures come from SingleCare’s live pricing pages, which vary by pharmacy and update frequently.
The NovoCare Pharmacy self-pay price
NovoCare Pharmacy is Novo Nordisk’s own direct-to-patient channel. Its published self-pay price is $349 per month for Wegovy pens at 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. One month is defined as one box of four pens, and home delivery is free.
That $349 is a recent number. Novo Nordisk announced in November 2025 that it was cutting the self-pay price from $499 to $349, and the company’s announcement also named partner channels including CVS pickup at more than 9,000 locations, Costco, GoodRx, WeightWatchers, Ro, LifeMD, and eMed. The $349 is not a NovoCare exclusive, but it does require going through a participating self-pay channel rather than handing a paper prescription to any pharmacy.
The $199 introductory offer and when it ends
New self-pay patients pay $199 per month for their first two monthly fills. Novo Nordisk’s price guide footnote states the offer covers two monthly fills through December 31, 2026, after which the price returns to $349 per month for standard doses and $399 per month for Wegovy HD.
That is $300 saved across your first two months if you are starting the drug. The offer is tied to being new to self-pay Wegovy, so it is worth confirming your eligibility before your first fill rather than after.
Wegovy tablets are the cheapest branded option
Oral semaglutide sold as Wegovy tablets is priced well below the pens. Novo Nordisk’s self-pay price is $149 per month for the 1.5 mg dose, $199 for 4 mg, and $299 for the 9 mg and 25 mg doses, with one month defined as one bottle of 30 tablets. The 4 mg dose was also $149 until that promotional price ended August 31, 2026, so the tablet ladder now steps up one rung sooner than it did over the summer.
At $149, the 1.5 mg tablet is the least expensive branded semaglutide on the US market for a cash payer. Whether a tablet or an injection is right for you is a clinical question for your prescriber, not a budgeting one, but it is worth knowing the price gap exists before that conversation.
What TrumpRx lists
TrumpRx (trumprx.gov) is the federal site launched in early 2026 that publishes negotiated cash prices and routes you to the manufacturer’s program or a partner pharmacy. It is not itself a pharmacy.
As of September 2, 2026 it lists the Wegovy pill at $149 per month and the Wegovy pen at $199 per month, both against an original price of $1,349. Those headline numbers correspond to the lowest tier of Novo Nordisk’s own program (the introductory offer and the starting tablet dose), so what you pay long term will usually match the NovoCare prices above. It costs nothing to check, and it is a legitimate front door to the same discounts. Our fair price checker is a useful second stop when you want to sanity-check any quote you are given.
What Wegovy costs at a regular pharmacy counter
If you fill Wegovy at a pharmacy with no manufacturer program and no insurance, you pay something close to list. SingleCare’s Wegovy pricing pages in August 2026 show a typical cash price of roughly $1,772 to $1,820 for a 30-count bottle of 1.5 mg tablets, dropping to about $1,011 to $1,086 with a SingleCare coupon at Kroger or Harris Teeter. For pens, SingleCare shows roughly $1,209 for four 2.4 mg prefilled pens at Publix.
Note that SingleCare’s own pages carry slightly different figures depending on which formulation and pharmacy you look at, which is normal for live coupon pricing. The point holds either way: even the best coupon price at a retail counter is roughly three times the manufacturer’s self-pay price.
What Drives the Price
Which channel you buy through. This is the single biggest factor, worth about $1,000 a month. The same four pens cost $349 through a participating self-pay channel and over $1,200 at a random pharmacy counter.
Pen versus tablet. Oral Wegovy at $149 per month undercuts the injection at $349. Two formulations of the same molecule, priced more than twice apart.
Standard dose versus Wegovy HD. Every standard pen dose is flat at $349, so titrating up does not raise your bill. The high-dose 7.2 mg pen is the exception at $399 per month.
Whether you are new to self-pay. The $199 introductory price applies only to your first two monthly fills, and only through December 31, 2026.
Published end dates. Novo Nordisk attaches expiration dates to its promotional tiers. The $149 price on the 4 mg tablet expired on August 31, 2026 and that dose is now $199, and the $199 introductory pen price is scheduled to end December 31, 2026. Prices in this category have moved repeatedly since 2024, so recheck before each refill cycle.
Cash Price vs. Insurance
Wegovy is unusual: for a lot of people, insurance simply is not an option. KFF’s analysis of 2024 federal Marketplace plan data found Wegovy was covered by just 1% of Marketplace prescription drug plans, compared with 82% for Ozempic, which contains the same active ingredient but is approved for diabetes. Insurers restrict by indication, not by molecule.
If you do have commercial coverage that includes it, use the savings card. Novo Nordisk’s card lets eligible commercially insured patients pay as little as $25 per month, with savings capped at $100 per month. People with Medicare, Medicaid, or other government coverage are excluded from the card.
Medicare is its own case. Part D is prohibited by law from covering drugs used only for weight loss, but a federal demonstration called the Medicare GLP-1 Bridge began July 1, 2026 and runs through December 31, 2027, offering eligible beneficiaries a $50 monthly copay, according to KFF. KFF also notes that copay does not count toward the Part D deductible or the annual out-of-pocket maximum. Separately, semaglutide’s Medicare negotiated price takes effect in 2027.
For everyone else, the $349 self-pay price is the real price, and it does not require being uninsured. If you have a high-deductible plan that excludes weight-loss drugs, the cash program is not a fallback; it is your primary option. Our guide to GLP-1 costs without insurance compares this against Zepbound and the tirzepatide brands side by side.
How to Pay Less
-
Buy through a participating self-pay channel. The $349 and $199 prices exist only inside Novo Nordisk’s program and its partner pharmacies. This one decision is worth about $1,000 a month.
-
Claim the introductory offer before it expires. New self-pay patients pay $199 per month for the first two fills through December 31, 2026, which is $300 you only get once.
-
Ask your prescriber about the tablet. At $149 per month for the 1.5 mg dose, oral Wegovy is $200 a month cheaper than the pens. Whether it fits your situation is a clinical call, but the price difference is worth raising.
-
Compare against the other semaglutide brands. Novo Nordisk sells the same molecule as Ozempic for diabetes and Rybelsus in tablet form, at different self-pay prices. Tirzepatide brands like Mounjaro and the older Saxenda price differently again. Which one you can be prescribed depends on your diagnosis, not your preference, but knowing the price map helps you ask the right question.
-
Handle the prescribing visit cheaply. These are prescription drugs, so budget for the appointment. A free or sliding-scale clinic can handle the visit and the ongoing check-ins at little or no cost, and a cash-pay doctor visit typically runs $50 to $150.
-
Use discount cards for everything else. Coupon cards rarely beat the manufacturer program on brand Wegovy, but they routinely cut the rest of a prescription list to a few dollars. See GoodRx vs. SingleCare for how the two compare. And if a clinic or lab bill from the workup catches you off guard, our guide to negotiating medical bills covers what to say.
The Bottom Line
Budget $349 a month for Wegovy pens without insurance, $399 if you are on the high-dose HD pen, or $149 a month if you and your prescriber land on the 1.5 mg tablet. Those are published prices from Novo Nordisk, re-checked on its own pages September 2, 2026, not estimates, and no insurance is required to get them.
Catch the $199 introductory price on your first two fills if you are starting out, and never fill Wegovy at a retail counter without checking the manufacturer channel first. The gap between the two is about $1,000 a month, which is the whole ballgame.